Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Abvc Biopharma's Return on Capital Employed [ROCE] was -45.76% in Q3 2026, up 0.66 percentage points from -46.43% a year earlier and up 1.21 percentage points from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Abvc Biopharma came in at -92.19%, up 333.72 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +100.12 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -425.91% in FY2024 (-163.65 pp), -262.26% in FY2023 (-14.29 pp), -247.97% in FY2022 (-117.33 pp) and -130.65% in FY2021 (+61.67 pp).
  • The Q3 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q2 2025.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +125.20 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2025 (a gain of 395.01 percentage points); the worst was Q4 2024 (a drop of 316.04 percentage points).
  • Per Business Quant data, ABVC's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was -46.97% (Q2 2026), -52.20% (Q1 2026) and -49.00% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -45.76%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -45.76%
Jun 30, 2026 -46.97%
Mar 31, 2026 -52.20%
Dec 31, 2025 -49.00%
Sep 30, 2025 -46.43%
Jun 30, 2025 -44.26%
Mar 31, 2025 -57.18%
Dec 31, 2024 -427.23%
Sep 30, 2024 -271.16%
Jun 30, 2024 -360.97%
Mar 31, 2024 -452.19%
Dec 31, 2023 -111.18%
Sep 30, 2023 -123.64%
Jun 30, 2023 -257.33%
Mar 31, 2023 -212.54%
Dec 31, 2022 -336.89%
Sep 30, 2022 -223.72%
Jun 30, 2022 -179.80%
Mar 31, 2022 -180.85%
Dec 31, 2021 -125.41%
API Access

Abvc Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY